TrialBMC cancer2015

BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.

Wouter Willaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.